
Assertio Holdings ASRT
€ 8.42
0.22%
Quartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Assertio Holdings P/S 2011-2025 | ASRT
P/S Jährlich Assertio Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.434 | 1.78 | 0.894 | 0.621 | 0.336 | 0.898 | 1.22 | 2.38 | 2.69 | 2.73 | 5.09 | 4.06 | 2.49 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.09 | 0.336 | 1.97 |
P/S anderer Aktien in der Arzneimittelhersteller
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | ||
|
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
0.528 | $ 1.21 | -7.63 % | $ 130 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | ||
|
Cronos Group
CRON
|
77.6 | $ 2.67 | -2.55 % | $ 1.44 B | ||
|
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | ||
|
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | ||
|
Aurora Cannabis
ACB
|
3.73 | $ 4.47 | -2.08 % | $ 86.3 M | ||
|
DURECT Corporation
DRRX
|
3.72 | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
0.432 | - | - | $ 36.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
6.01 K | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
0.719 | - | 2.45 % | $ 38.1 M | ||
|
Emergent BioSolutions
EBS
|
0.132 | $ 12.36 | -2.37 % | $ 633 M | ||
|
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
4.24 | $ 21.6 | 0.07 % | $ 2.06 B | ||
|
Evolus
EOLS
|
3.33 | $ 6.88 | 0.36 % | $ 427 M | ||
|
Harrow Health
HROW
|
2.67 | $ 50.08 | -0.16 % | $ 1.63 B | ||
|
China Pharma Holdings
CPHI
|
1 | $ 1.29 | -1.56 % | $ 22.5 M | ||
|
Organogenesis Holdings
ORGO
|
0.86 | $ 5.36 | -8.71 % | $ 706 M | ||
|
OrganiGram Holdings
OGI
|
4.82 | $ 1.8 | 1.99 % | $ 402 M | ||
|
Bausch Health Companies
BHC
|
0.386 | $ 7.19 | -0.07 % | $ 2.62 B | ||
|
Pacira BioSciences
PCRX
|
5.13 | $ 26.48 | 1.77 % | $ 1.22 B | ||
|
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | ||
|
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
8.49 | $ 4.11 | -2.14 % | $ 57.8 M | ||
|
Rockwell Medical
RMTI
|
0.424 | $ 0.87 | 7.18 % | $ 20.3 M | ||
|
Sundial Growers
SNDL
|
0.0158 | $ 1.75 | -1.13 % | $ 3.37 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 3.63 | -0.41 % | $ 4.5 M | ||
|
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | ||
|
Radius Health
RDUS
|
1.64 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | ||
|
Jupiter Wellness
JUPW
|
118 | - | - | $ 33.6 M | ||
|
Veru
VERU
|
6.39 | $ 2.37 | 1.28 % | $ 320 M | ||
|
Perrigo Company plc
PRGO
|
0.905 | $ 13.87 | 0.95 % | $ 1.91 B | ||
|
ProPhase Labs
PRPH
|
1.06 | $ 0.51 | -16.94 % | $ 8.08 M | ||
|
cbdMD
YCBD
|
0.0863 | $ 1.69 | 3.68 % | $ 7.29 M | ||
|
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
14.4 | - | -27.8 % | $ 2.56 M | ||
|
SCYNEXIS
SCYX
|
0.502 | $ 0.58 | -1.87 % | $ 27.8 M | ||
|
Tilray
TLRY
|
1.9 | $ 9.6 | -5.43 % | $ 5.93 B | ||
|
TherapeuticsMD
TXMD
|
18.4 | $ 1.72 | 0.88 % | $ 18 M | ||
|
Viatris
VTRS
|
0.837 | $ 12.33 | 0.69 % | $ 14.9 B | ||
|
Zynerba Pharmaceuticals
ZYNE
|
895 | - | - | $ 55.5 M |